{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:49:59Z","timestamp":1770011399191,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Predoctoral Interdisciplinary Training in Movement Disorders and Neurorestoration","award":["T32NS088768"],"award-info":[{"award-number":["T32NS088768"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS082672"],"award-info":[{"award-number":["R01NS082672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL69064"],"award-info":[{"award-number":["R01HL69064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Barbara's Dream Fund for Frontotemporal Dementia Research and Education"},{"name":"McKnight Brain Institute"},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.mcn.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T05:37:49Z","timestamp":1527831469000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis"],"prefix":"10.1016","volume":"92","author":[{"given":"Sruti","family":"Rayaprolu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasin B.","family":"Seven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelle","family":"Altshuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jada","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2018.05.009_bb0005","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/mds.22996","article-title":"Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations","volume":"25","author":"Behrens","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0010","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0015","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archneurol.2010.281","article-title":"Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype","volume":"67","author":"Br\u00fcggemann","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2018.05.009_bb0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ajmg.b.31214","article-title":"ATP13A2 variability in Taiwanese Parkinson's disease","volume":"156B","author":"Chen","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0025","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/jnr.23112","article-title":"Characterization of cellular protective effects of ATP13A2\/PARK9 expression and alterations resulting from pathogenic mutants","volume":"90","author":"Covy","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2018.05.009_bb0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.parkreldis.2010.10.011","article-title":"Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation","volume":"17","author":"Crosiers","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0035","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1073\/pnas.1112368109","article-title":"Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration","volume":"109","author":"Dehay","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.05.009_bb0040","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.05.009_bb0045","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/mds.22728","article-title":"ATP13A2 variants in early-onset Parkinson's disease patients and controls","volume":"24","author":"Djarmati","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1399-0004.2011.01745.x","article-title":"Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9)","volume":"82","author":"Eiberg","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/brain\/aww307","article-title":"Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)","volume":"140","author":"Estrada-Cuzcano","year":"2017","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.mcn.2018.05.009_bb0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nbd.2011.02.009","article-title":"A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers","volume":"42","author":"Farias","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2018.05.009_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2010.03.018","article-title":"Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China","volume":"475","author":"Fei","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2018.05.009_bb0070","article-title":"The effect of manganese exposure in Atp13a2-deficient mice","author":"Fleming","year":"2017","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.mcn.2018.05.009_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0","article-title":"A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease","volume":"59","author":"Giasson","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2018.05.009_bb0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2018.05.009_bb0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.300","article-title":"Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"Gitler","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/sageke.2005.5.re1","article-title":"Lipofuscin and aging: a matter of toxic waste","volume":"2005","author":"Gray","year":"2005","journal-title":"Sci. Aging Knowl. Environ."},{"key":"10.1016\/j.mcn.2018.05.009_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40478-014-0133-7","article-title":"Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV","volume":"2","author":"Grishchuk","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.mcn.2018.05.009_bb0100","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/mds.22156","article-title":"Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset parkinsonism","volume":"23","author":"Guo","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0105","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/jmg.38.10.680","article-title":"Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36","volume":"38","author":"Hampshire","year":"2001","journal-title":"J. Med. Genet."},{"issue":"191","key":"10.1016\/j.mcn.2018.05.009_bb0110","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.4049\/jimmunol.1301490","article-title":"Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation","volume":"1950","author":"Heid","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.mcn.2018.05.009_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.mcn.2018.05.009_bb0120","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","article-title":"\u03b1-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal parkinsonism protein Atp13a2","volume":"35","author":"Kett","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2018.05.009_bb0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrm1354","article-title":"Biology, structure and mechanism of P-type ATPases","volume":"5","author":"K\u00fchlbrandt","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mcn.2018.05.009_bb0130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature05453","article-title":"Genome-wide atlas of gene expression in the adult mouse brain","volume":"445","author":"Lein","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2018.05.009_bb0135","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000335167.72412.68","article-title":"Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore","volume":"71","author":"Lin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.05.009_bb0140","first-page":"5483","article-title":"Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance","volume":"25","author":"Lubbe","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2014.06.023","article-title":"Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features","volume":"577","author":"Malakouti-Nejad","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2018.05.009_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.parkreldis.2009.11.010","article-title":"ATP13A2 G2236A variant is rare in patients with early-onset Parkinson's disease and familial Parkinson's disease from mainland China","volume":"16","author":"Mao","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0155","first-page":"459","article-title":"New applications of the Luxol fast blue myelin stain","volume":"5","author":"Margolis","year":"1956","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.mcn.2018.05.009_bb0160","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.febslet.2013.02.046","article-title":"ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons","volume":"587","author":"Matsui","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mcn.2018.05.009_bb0165","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2018.05.009_bb0170","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/01.wnl.0000310427.72236.68","article-title":"PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype","volume":"70","author":"Ning","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.05.009_bb0175","doi-asserted-by":"crossref","first-page":"32926","DOI":"10.1074\/jbc.M114.579961","article-title":"The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation","volume":"289","author":"Okada","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2018.05.009_bb0180","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations","volume":"25","author":"Pais\u00e1n-Ruiz","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/humu.21527","article-title":"Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism","volume":"32","author":"Park","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mcn.2018.05.009_bb0190","article-title":"Single heterozygous ATP13A2 mutations cause cellular dysfunction associated with Parkinson's disease","author":"Park","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0195","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.mcn.2018.05.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039942","article-title":"Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism","volume":"7","author":"Podhajska","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2018.05.009_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","article-title":"Late onset neurodegeneration in the Cln3\u2212\/\u2212 mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation","volume":"1023","author":"Pontikis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2018.05.009_bb0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cns.12514","article-title":"Atp13a2 deficiency aggravates astrocyte-mediated neuroinflammation via NLRP3 inflammasome activation","volume":"22","author":"Qiao","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.mcn.2018.05.009_bb0215","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","article-title":"Human NCL neuropathology","volume":"1852","author":"Radke","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2018.05.009_bb0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/mds.22399","article-title":"Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease","volume":"24","author":"Rakovic","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0225","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0230","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1016\/j.ajpath.2016.08.006","article-title":"Lysosomal storage of subunit c of mitochondrial ATP synthase in brain-specific Atp13a2-deficient mice","volume":"186","author":"Sato","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2018.05.009_bb0235","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22947","article-title":"ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation","volume":"25","author":"Schneider","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2018.05.009_bb0240","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited \u03b1-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0245","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2018.05.009_bb0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00690197","article-title":"Familial disorder of the central and peripheral nervous systems with particular cytoplasmic lamellated inclusions in peripheral nerves, muscle satellite cells, and blood capillaries","volume":"68","author":"Tom\u00e9","year":"1985","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.mcn.2018.05.009_bb0255","doi-asserted-by":"crossref","first-page":"15281","DOI":"10.1523\/JNEUROSCI.1629-14.2014","article-title":"ATP13A2\/PARK9 regulates secretion of exosomes and \u03b1-synuclein","volume":"34","author":"Tsunemi","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2018.05.009_bb0260","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1093\/hmg\/dds206","article-title":"Identification of novel ATP13A2 interactors and their role in \u03b1-synuclein misfolding and toxicity","volume":"21","author":"Usenovic","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2018.05.009_bb0265","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","article-title":"Deficiency of ATP13A2 leads to lysosomal dysfunction, \u03b1-synuclein accumulation, and neurotoxicity","volume":"32","author":"Usenovic","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2018.05.009_bb0270","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/humu.20877","article-title":"ATP13A2 variability in Parkinson disease","volume":"30","author":"Vilari\u00f1o-G\u00fcell","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mcn.2018.05.009_bb0275","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","article-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation","volume":"97","author":"Wada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.05.009_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002304","article-title":"A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier","volume":"7","author":"W\u00f6hlke","year":"2011","journal-title":"PLoS Genet."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743118300988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743118300988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:07:17Z","timestamp":1760922437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743118300988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":56,"alternative-id":["S1044743118300988"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2018.05.009","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}